Clinical Trial

Latitude - Lateral Lymph Node Attitude Study

Study acronym: Latitude
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Patients with advanced rectal cancer can sometimes have suspected tumour affected lymph nodes outside the standard operating field. These patients often receive preoperative treatment before surgery. There is a lack of consensus on what to do if there is remaining suspicion of tumour affected lymph nodes after the preoperative treatment. Removal of the lymph nodes using a broader surgical field with dissection of the lateral side-wall is often suggested, but the oncologic outcome is uncertain, and so is the patient reported outcome in terms of side effects. This study aims to study the surgical treatment of tumour affected lateral lymph nodes to understand what lymph nodes require removal, and what effect that will have on oncologic outcome and the patient's function and QoL.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-19.
Trial Details
NCT Number NCT06896578
Lead Sponsor Sahlgrenska University Hospital
Collaborators: Göteborg University
Conditions Rectal Neoplasm Malignant
Enrollment 1,000 participants
Start Date 2025-09-15
Primary Completion 2029-02-01 (estimated)
Study Completion 2034-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-08-08